Repare to lay off 75% of staff; Castle Creek inks $75M royalty deal

Plus, news about BioCity Biopharma, Kiniksa, Inceptor Bio, Ryvu Therapeutics, RedHill, VarmX, Paradox Immunotherapeutics and Lava Therapeutics:

Repare Therapeutics lays off 75% of staff: …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Study: Most stroke survivors can safely take two types of common antidepressants

Most stroke survivors were able to safely take two types of common antidepressants, according to a preliminary study to be presented at the American Stroke

February 1, 2024

PathAI and Google Cloud Partner to Advance AI-Powered Pathology for Biopharma and Labs

What You Should Know: – PathAI, a leading force in AI-powered pathology, has joined forces with Google Cloud at the Bio-IT World Conference & Expo

April 17, 2024

Apex Labs Receives Approval for US-Based Secondary GMP Psilocybin Supplier by Health Canada | Psychedelic Invest

Apex Labs Ltd., a pharmaceutical company transforming the standard of mental health care with clinically proven psilocybin treatments, announces Health Canada Approval of the company’s secondary

June 12, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.